In the news

The systems are designed to deliver paresthesia-free pain relief in minutes. They are designed with Boston Scientific’s Fast-Acting Sub-perception Therapy (FAST) and have four MRI conditional, Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators.

In an effort to solve unemployment issues caused by the coronavirus pandemic and overcome language barriers in the growing Latino and Hispanic population in his community, an immigrant from Costa Rica helped launch an all Spanish-language work shift for Hispanic workers at a medical manufacturing company in Spencer.

Reusable duodenoscopes infected patients in a series of notorious outbreaks. Now there’s a disposable model to be used just once.

SVP Brad Sorenson gives context on how hospitals have recovered during the COVID-19 pandemic and are learning to bifurcate their business to handle both pandemic patients and more typical cases.

Boston Scientific has secured FDA approval for its Ranger paclitaxel-coated balloon, designed to help limit a patient’s systemic exposure to the chemotherapy used to slow the closure of reopened arteries.

“The CHAMPION-AF trial will compare the Watchman FLX device in a head-to-head fashion against best-in-class pharmacological therapy for stroke prevention and evaluate the technology as a first-line therapy for those who can tolerate anticoagulation,” said Ian Meredith, global chief medical officer, Boston Scientific.

How evolving treatment pathways are improving communication and care—both in person and remotely.

HR VP Camille Chang Gilmore explains why Boston Scientific is using data to shine light on healthcare inequality.

Boston Scientific has a plan to tackle systemic racism in healthcare, and to stop the "Black amputation epidemic."

Boston Scientific’s WaveWriter Alpha systems garnered CE Mark approval with indications for managing chronic intractable pain and peripheral nerve stimulation of the trunk for pain management.